MUSTANG BIO, INC. Class of Warrant or Right, Outstanding
MUSTANG BIO, INC. (MBIO) had Class of Warrant or Right, Outstanding of 4.34 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-05
- 2026-06-30: Class of Warrant or Right, Outstanding 4.34M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 4.34M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 4.68M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 4.68M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 4.34M shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 4.34M shares 10-Q · filed 2026-05-05 | |
| 2025-12-31 | 4.68M shares 10-Q · filed 2026-08-05 | |
| 2025-09-30 | 4.68M shares 10-Q · filed 2025-11-07 | |
| 2025-06-30 | 7.54M shares 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 8.54M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 1.58M shares 10-K · filed 2026-03-19 | |
| 2024-09-30 | 60.96M shares 10-Q · filed 2024-11-08 | |
| 2024-06-30 | 60.96M shares 10-Q · filed 2024-08-13 | |
| 2023-12-31 | 89.62K shares 10-K · filed 2026-03-19 | 4.48M shares 10-Q · filed 2024-08-13 |
| 2022-12-31 | 1.39K shares 10-K · filed 2025-03-28 | |
| 2021-12-31 | 220.58K shares 10-K · filed 2024-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |